
0.cached.png
By Sarah Schafer
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Five months after Mahmoud Ahmadinejad's election as president of Iran, some leading figures in Tehran's "mullahcracy" who backed him as a candidate are desperately trying to rein him in. Last week Iran's Parliament rejected his third nominee for the vital post of Oil minister. And tougher fights loom ahead, as his opponents marshal their forces in the judiciary and the regular Army. Clearly Ahmadinejad has lost the full faith of Ayatollah Ali Khamenei, supreme leader of the Islamic republic. The reason: the new president's choice of mentor, Ayatollah Mohammad Taqi Mesbah-Yazdi.
The man is ultra-fundamentalist with a mystical bent. He is affiliated with the Hojjatieh movement, which is preparing for the return of the 12th imam, who disappeared down a well in the ninth century. The group's teachings undermine the authority of any contemporary "supreme leader," like Khamenei. Thus, in supporting a president who venerates the missing imam above all else and who increasingly holds the loyalty of fundamentalist militants, "Khamenei made a deal with a devil far more powerful than he ever imagined," says Abbas Milani, an Iran expert at Stanford University. Hojjatieh is also said to believe that creating chaos on earth is a virtue, helping to prepare the way for the imam's second coming.
With tensions mounting in Tehran, the Bush administration has steadily toned down its attacks on the Iranian regime. Last week Washington took a back seat while Europe and Russia tried to hammer out a compromise that would stop Iran from making nuclear fuel. With the mullahs now tearing themselves apart, the last thing Washington wants to do is scare them into a new unity.
Read More on News
Rather than sailing smoothly into a crucial financial summit in December, the EU seems to be cruising for a bruising. Last week in Brussels, the Union's 2006 budget talks collapsed. The 25 foreign ministers couldn't evenagree on where to cap EU spending. "We are sitting here wasting our time," Belgian Foreign Minister Karel De Gucht told reporters. And with British Prime Minister Tony Blair hoping to lay out long-term reform plans for the expensive farm subsidies that swallow almost half the Union's budget next month, their time is becoming increasingly valuable.
Some analysts believe new German Chancellor Angela Merkel can break the EU logjam--if she sends the right signals. Last week she told reporters that Germany would no longer pursue alliances at the expense of other members. (Take notice, France.) She also pledged to patch up relations with Washington (another divisive EU issue) and offered Blair her assistance on the budget, even as she vowed to keep the 1 percent budget cap at home. The 2002 deal to extend present farm subsidies until 2013 won't be touched, either.
If only this were Europe's only problem. Angry at Old Europe's failure to resolve its differences, the eight newest EU members are turning fractious, too. Hungary recently refused to bring its budget deficit in line with EU policy. Opinion polls in the Baltic states show declining support for joining the euro, and Poland has a new Euroskeptic government. Good luck in December, Europe.
It's the responsibility of the media to look at government--especially the president--with a microscope... But when they use a proctoscope, it's going too far." So said former U.S. president Richard Nixon, shortly before nosy journalists drove him out of office. Now Thai Prime Minister Thaksin Shinawatra is getting the Nixon treatment. Since his election in 2001, Thaksin has come under brutal fire for his mishandling of Muslim separatism in southern Thailand, not to mention his failure to turn around the country's sluggish economy. Lately the media has gotten more personal. "When he's serious, people don't like it, and when he tries to make a joke, people don't like it," says Bangkok-based political analyst Chayachoke Chulasiriwongs.
It's bad enough being ridiculed. But lately, Thaksin has confounded his troubles by misadvisedly trying to muzzle the source. Recently the business tycoon turned P.M. issued a defamation lawsuit against his chief adversary, prominent media mogul Sondhi Limthongkul. But that provoked a predictable pro-Sondhi media storm. And last week, a Bangkok court lifted a government-issued gag order against Sondhi, ruling that it couldn't ban him from criticizing the P.M. while the defamation charges are pending. These latest blows now have Thaksin seeing stars--literally. "Right now Mercury... is in a corner perfectly aligned with my star," he declared last week, saying that he would only speak to reporters again once his astrological signs were re-aligned to his advantage. "Mercury is no good." Time will tell whether a telescope will help Thaksin escape the proctoscope treatment.
Hwang Woo-Suk may be a scientist, but in South Korea, he's virtually a rock-and-roll star. The first researcher to extract stem cells from a cloned human embryo, Hwang even has an Internet fan club. In October, after he announced plans for a vast international stem-cell institute, his popularity went platinum. But last week it turned out he lied. In 2002 and 2003, Hwang's lab was facing a shortage of the human eggs it needed to perform research, so two of his subordinates donated their own. An affiliated hospital paid several more women about $1,400 each to do the same. At the time, Hwang said that volunteers had donated all the eggs in his experiments without compensation. He may have believed his own statement; the staffers participated under false names. But after he learned where the eggs really came from, he kept the truth quiet, only fessing up last week.
Hwang's dream of a vast international network of stem-cell researchers may now be in danger. In his apology, Hwang said he had gotten "preoccupied with work and achievement" to keep ethical considerations in mind, and that the science had outpaced regulations--a defense that plays right into the hands of some U.S. opponents of stem-cell research.
While millions of Chinese scrambled to stock up on water after it was revealed that a November explosion at a plant in a neighboring province of Harbin had flooded the Songhua River with toxins, Chinese activists readied themselves for a battle with polluters and government officials who tried to cover it up. Initially, provincial and company officials had denied there was any environmental damage. But a few honest officials and some enterprising journalists made sure the truth came out. Now most of the world knows that the explosion released some 100 tons of toxins into the Songhua. At one point, benzene in the river near Harbin rose to 30 times the safe level. As of Saturday, toxins were still nearly twice the acceptable level.
Will the environmentalists win? The ruling Communist Party often crushes attempts at grass-roots activism, but increasingly, brave lawyers, feisty journalists and even a few maverick bureaucrats are demanding information from corporations and government agencies about the harmful side effects of rapid economic development. And public anger could continue to rise. Beijing lawyer Hu Fengbin--already representing one Harbin resident in a lawsuit against the chemical plant--thinks he'll have plenty more calls from people eager to join his case against the state-owned company. Although he knows he might not win--he isn't even sure that a judge will hear the case--he measures progress in small steps. "Another reason to take the case is to let the chemical company hear the voice of the people," he says. After so many years of silence, that voice could be a powerful one indeed.
There are the books we read, the books we mean to read and then there are the ones--c'mon, admit it--that mainly just look impressive on the shelf. Take "A Brief History of Time": the classic has sold more than 10 million copies--but good luck finding people who have finished it.
A recent study of 2,100 Brits found that more than a third of them buy certain titles solely to look intelligent--a bit of statistical confirmation of "book snobbism," something long suspected in literary circles. "It does ring true," says Mark Tavani, an editor at Random House. "Certain books will sell, and you're left wondering, 'Are people really reading this thing?' " According to various members of the literati, certain recent titles are notorious for having sales figures that belie their readability: Michael Faber's "The Crimson Petal and the White," Elizabeth Kostova's "The Historian" and Zadie Smith's "White Teeth," to name a few. "The God of Small Things," said one top editor who did not want to criticize a competitor's book on the record, "is a total smarty-pants buy. Some people definitely found it to be a very beautiful book, but the large majority of people bought it just because it was the thing to buy."
Unmoved by Mel Gibson's "whitewashed" telling of Jesus' life in "The Passion of the Christ," New York artist and Episcopalian Steve Ross embarked on a graphic novel based on the Gospel of Mark to shake up the evangelicals who flocked to the flick. "I said, here's my chance to finally get even with all the right-wing, neocon, fundamentalist, holy-rolling, snake-handling crazies who I feel have co-opted Christianity." True to its mission, "Marked" restores the inherent weirdness of the story by messing with conventions: a clean-shaven Jesus performs violent exorcisms, the angel at the tomb wears a clown costume and the Devil tempts Jesus from a limo. ("Simply perfect. Not too white, not too ethnic. Young. Strong. Male though slightly androgynous... Have your people call my people.") As Ross explored the themes of passion and murder, love and law, he started to inject a reverence into his irreverence. In the end, "the book became about loving those who are marginalized," he says.
If you want to win an Oscar for best actor this year, you're too late. Only five men get nominated, and four of those slots may already be taken. With less than two months to go until the nominations are announced, the fight for that fifth nom could get a little bloody. But first, the front runners.
Philip Seymour Hoffman struts his star-size talent in "Capote," capturing Truman Capote's distinctive speech and drilling into the famous author's psyche. In "Walk the Line," Joaquin Phoenix reveals the pain and sorrow behind Johnny Cash's music (and does his own singing). Heath Ledger breaks hearts in "Brokeback Mountain," playing a ranch hand in love with another man, tortured by his desires and his fears. Nominations for those three men are considered guaranteed, according to the Academy voters, strategists and industry insiders interviewed for this story. The fourth spot will likely go to David Strathairn for "Good Night, and Good Luck," directed by George Clooney. Strathairn, a highly respected character actor, stars as revered journalist Edward R. Murrow. "When the movie screened at the Academy, there was resounding applause when his name came up," says one Academy member, who, like others in the industry, doesn't comment on the Oscar race publicly. "It would be wonderful to see him get nominated."
So who will get the final slot? Not every film has screened yet, so this list may change, but the field's already crowded. Terrence Howard generated heat earlier this year for his pimp-rapper role in "Hustle & Flow," but one strategist predicts he'll be overlooked. "He's this year's Paul Giamatti," he says. Irish actor Cillian Murphy is getting buzz for his transvestite role in Neil Jordan's "Breakfast on Pluto," but it may prove too outre. "The Constant Gardener" could grow a third nom for Ralph Fiennes, and "The Producers" might just laugh up a first for Nathan Lane. Clooney is throwing his hat in the ring for "Syriana," but he's more likely to score a best-director nom for "Good Night." The final wild card is Russell Crowe for "Cinderella Man." "He cannot be overlooked any year," says one insider. But that still may not be enough to compensate for his infamous temper problem. "People think he's a putz ," says one Oscar voter. "I think the Academy may take a Crowe break." Which could give a very big break to someone else.
Submit Correction
View Editorial & AI Guidelines